NewsCorona inactivated vaccine Novavax: One factor is delaying approval

Corona inactivated vaccine Novavax: One factor is delaying approval

Several billion doses of Novavax’s new protein-based Covid vaccine should be delivered in 2021. But there is still a problem at one point.

Gaithersburg – Many are longingly waiting for the Covid vaccine from Novavax – because this differs from the previous vaccines and promises a high level of effectiveness. As early as 2020, Novavax managing director Stanley Erck announced that deliveries of up to two billion vaccine doses could be expected in 2021. So far, however, the approval is pending. Will that change anytime soon?

In contrast to the mRNA vaccines from Biontech and Moderna, which are currently considered the most popular, immunization with the vaccine from the Novavax company is carried out using protein particles. This means that the vaccine contains laboratory-produced particles of the Sars-CoV-2 protein, which trigger the production of antibodies in the body. In contrast to mRNA vaccines, which contain parts of the genetic information of the virus, vaccination with protein-based vaccines has been tried and tested for a long time – an argument with which vaccination skeptics can still be convinced of a vaccination against corona. In addition, experts rate such a vaccine as particularly effective.

Novavax Corona Vaccine: CEO Announces Emergency Authorization Application

After the CEO of Novavax in the USA had already spread hope for an early approval in 2020, he now again emphasized to CNN that he was planning to submit an application for emergency approval of the vaccine to the American drug regulatory authority FDA this year. However, delayed studies and slow production in the past have made global release of the vaccine impossible so far.

The vaccine is only approved in Indonesia and the Philippines. Several approval processes are currently underway, for example in Europe, Great Britain, Canada and Australia, but until the production problems of the small company are resolved, approval is unlikely to be expected. In the USA, for example, the approval is largely related to whether companies can deliver their products without restrictions. But Novavax boss Erck is confident that the problems have been overcome.

Novavax: Corona vaccine – means is already being adapted against the Omikron variant

Because after the US government has already funded the vaccine company with 1.6 billion dollars, Novavax has now joined forces with the Serum Institute of India, the world’s largest manufacturer of vaccines, according to Wiwo. Silvia Taylor, Vice President Of Global Corporate Affairs And Investor Relations at Novavax, is convinced that the company will be able to produce more than two billion vaccine doses by 2022. In addition, the company promised that the vaccine is currently being adapted to the new Omikron variant.

With the new Omikron variant, the global corona situation is getting worse. The current developments regarding the mutation in the ticker. (tt)

Booster chaos in Johnson vaccinated: What now applies in Bavaria, North Rhine-Westphalia, Saxony and...

The booster campaign is running in Germany. As a rule, vaccinated people need a third vaccination - a booster vaccination against the corona virus. But who is actually considered boosted?

Vaccinated and recovered: where you are now considered boosted – and where not

The corona rules between the federal states differ massively. This becomes clear when it comes to booster status.

AstraZeneca: New study results show protective strength against omicron

AstraZeneca's corona vaccine is no longer vaccinated in Germany - a mistake? A new study examined its effectiveness against omicron.

Lauterbach with bad news: "The Delta variant is currently changing" – and could be...

Karl Lauterbach has reason to worry about the sharp increase in the number of cases caused by the omicron variant. He even thinks another mutation of the virus is likely in the fall.

Corona in Germany: There is no wave of layoffs in clinics – falling numbers...

The corona numbers continue to rise, and the RKI reports a new maximum incidence value. The incidence is now jumping nationwide over a mark of 550. The news ticker.